Tirabrutinib
| CAS No. | 1351636-18-4 |
|---|---|
| MDL No. | MFCD28386296 |
| MF | C25H22N6O3 |
| MW | 454.50 |
| InChI Key | SEJLPXCPMNSRAM-GOSISDBHSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Tirabrutinib is an orally available BTK inhibitor with potential antineoplastic activity. It covalently binds to BTK in B cells, blocking B cell receptor signaling and inhibiting B cell development, thereby suppressing the proliferation of B cell malignancies.
| CAS No. | 1351636-18-4 |
|---|---|
| Product Name | Tirabrutinib |
Biological Targets
BTK
Associated Conditions
neoplasm·rheumatoid arthritis·non-Hodgkins lymphoma·chronic idiopathic urticaria·Sjogren syndrome·
* The information provided here is compiled from public sources and is for reference only.
